RETRACTED: Long noncoding RNA OR3A4 promotes the migration and invasion of melanoma through the PI3K/AKT signaling pathway (Retracted article. See vol. 24, pg. 10917, 2020)

被引:8
|
作者
Wu, J. [1 ]
Zhou, M-Y [1 ]
Yu, X-P [1 ]
Wu, Y. [1 ]
Xie, P-L [2 ]
机构
[1] Peoples Hosp Gansu Prov, Dept Burns, Lanzhou, Gansu, Peoples R China
[2] Peoples Hosp Gansu Prov, Dept Plast Surg, Lanzhou, Gansu, Peoples R China
关键词
Long non-coding RNA; OR3A4; Melanoma; PI3K/AKT signaling pathway; PREDICTS POOR-PROGNOSIS; CELL-CYCLE ARREST; PROLIFERATION; METASTASIS; APOPTOSIS; CANCER;
D O I
10.26355/eurrev_201908_18739
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: Recent studies have revealed the crucial role of long non-coding RNAs (lncRNAs) in tumor progression. This study aims to identify the biological function of lncRNA OR3A4 in the progression of melanoma. PATIENTS AND METHODS: OR3A4 expression in melanoma cells and tissue samples was detected by Real Time-quantitative Polymerase Chain Reaction (RT-qPCR), The regulatory effects of OR3A4 on melanoma cells were identified by performing transwell assay and wound healing assay in vitro. The underlying mechanism of OR3A4 in mediating the progression of melanoma was explored by RT-qPCR and Western blot. RESULTS: OR3A4 expression was remarkably upregulated in melanoma tissues compared with normal tissues. Moreover. migration and invasion of melanoma cells were inhibited after knockdown of OR3A4 in vitro, which were promoted after overexpression of OR3A4. Furthermore, the targeted proteins in phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) signaling pathway were downregulated after knockdown of OR3A4 in vitro, which were upregulated by overexpressed OR3A4. CONCLUSIONS: OR3A4 could promote the invasion and migration of melanoma cells by inducing the PI3K/AKT signaling pathway, which may offer a new therapeutic intervention for melanoma patients.
引用
收藏
页码:6991 / 6996
页数:6
相关论文
共 50 条
  • [31] RETRACTED: Erinacine Facilitates the Opening of the Mitochondrial Permeability Transition Pore Through the Inhibition of the PI3K/Akt/GSK-3β Signaling Pathway in Human Hepatocellular Carcinoma (Retracted article. See vol. 55, pg. 674, 2021)
    Zhou, Li-Jie
    Mo, Yan-Bo
    Bu, Xuan
    Wang, Jian-Jun
    Bai, Jing
    Zhang, Jun-Wei
    Cheng, Ai-Bin
    Ma, Ji-Hong
    Wang, Yi-Wei
    Xie, Yu-Xi
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 50 (03) : 851 - 867
  • [32] RETRACTED: LncRNA CASC15 promotes migration and invasion in prostate cancer via targeting miR-200a-3p (Retracted article. See vol. 24, pg. 7215, 2020)
    Zhang, C.
    Wang, G-X
    Fu, B.
    Zhou, X-C
    Li, Y.
    Li, Y-Y
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (19) : 8303 - 8309
  • [33] RETRACTED: Exosomes transferring long non-coding RNA FAL1 to regulate ovarian cancer metastasis through the PTEN/AKT signaling pathway (Retracted article. See vol. 24, pg. 10921, 2020)
    Zhang, Q.
    Len, T-Y
    Zhang, S-X
    Zhao, Q-H
    Yang, L-H
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (01) : 43 - 54
  • [34] RETRACTED: MicroRNA-191-5p promotes the development of osteosarcoma via targeting EGR1 and activating the PI3K/AKT signaling pathway (Retracted article. See vol. 25, pg. 3145, 2021)
    Chen, B.
    Zheng, Z-Y
    Yang, J-Z
    Li, X-G
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (09) : 3611 - 3620
  • [35] RETRACTED: Long noncoding RNA DARS-AS1 acts as an oncogene by targeting miR-532-3p in ovarian cancer (Retracted article. See vol. 24, pg. 7211, 2020)
    Huang, K.
    Fan, W-S
    Fu, X-Y
    Li, Y-L
    Meng, Y-G
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (06) : 2353 - 2359
  • [36] RETRACTED: Long noncoding RNA PANDAR promotes progression and predicts poor prognosis via upregulating ROCK1 in prostate cancer (Retracted article. See vol. 24, pg. 11466, 2020)
    Yang, J.
    Zhao, S.
    Li, B.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (11) : 4706 - 4712
  • [37] RETRACTED: Long non-coding RNA MEG3 inhibits cell growth of gliomas by targeting miR-93 and inactivating PI3K/AKT pathway (Retracted article. See vol. 45, pg. 407, 2021)
    Zhang, Ling
    Liang, Xin
    Li, Yuxiong
    ONCOLOGY REPORTS, 2017, 38 (04) : 2408 - 2416
  • [38] RETRACTED: Nimotuzuma restrains proliferation and induces apoptosis in human osteosarcoma cells by regulation of EGFR/PI3K/AKT signal pathway (Retracted article. See vol. 236, pg. 8257, 2021)
    Liu, Meihan
    Zhang, Jingzhe
    Dong, Hang
    Wang, Wenjun
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (11) : 20879 - 20887
  • [39] RETRACTED: AIB1 induces epithelial-mesenchymal transition in gastric cancer via the PI3K/AKT signaling (Retracted article. See vol. 122, pg. 1973, 2021)
    Diao, Lei
    Li, Yang
    Mei, Qiao
    Han, Wei
    Hu, Jing
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2021, 122 (09) : 926 - 933
  • [40] RETRACTED: MicroRNA-1297 contributes to tumor growth of human breast cancer by targeting PTEN/PI3K/AKT signaling (Retracted article. See vol. 50, pg. 180, 2023)
    Liu, Chao
    Liu, Zhikui
    Li, Xiao
    Tang, Xiaojiang
    He, Jianjun
    Lu, Shaoying
    ONCOLOGY REPORTS, 2017, 38 (04) : 2435 - 2443